Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

BI-135585

🥰Excellent
Catalog No. T26794Cas No. 1114561-85-1
Alias BI135585, BI 135585

BI-135585 is an orally active, selective and potent inhibitor of human 11β-hydroxysteroid dehydrogenase-1 (HSD1) for the study of type 2 diabetes.

BI-135585

BI-135585

🥰Excellent
Purity: 99.66%
Catalog No. T26794Alias BI135585, BI 135585Cas No. 1114561-85-1
BI-135585 is an orally active, selective and potent inhibitor of human 11β-hydroxysteroid dehydrogenase-1 (HSD1) for the study of type 2 diabetes.
Pack SizePriceAvailabilityQuantity
1 mg$290In Stock
5 mg$650In Stock
10 mg$980In Stock
25 mg$1,670In Stock
50 mg$2,180In Stock
Bulk & Custom
Add to Cart
Questions
View More
Select Batch
Purity:99.66%
ee:100%
Contact us for more batch information
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
BI-135585 is an orally active, selective and potent inhibitor of human 11β-hydroxysteroid dehydrogenase-1 (HSD1) for the study of type 2 diabetes.
Targets&IC50
the enzyme activity in abdominal subcutaneous adipose tissue (cynomolgus monkey):100 nM, the enzyme activity in perirenal adipose tissue (cynomolgus monkey):10 nM, 11β-HSD1:1 nM, conversion of corticosterone to cortisol:11 nM
In vitro
BI-135585 interacts with the substrate binding pocket of the 11β-HSD1 active site. In human preadipocytes, its inhibition of 11β-HSD1 activity was evaluated and found to have an average IC50 of 1 nM. In isolated human adipose tissue, BI-135585 blocked the conversion of corticosterone to cortisol at an average IC50 of 11 nM. [1]
A study of abdominal subcutaneous and perirenal adipose tissue from a male cynomolgus monkey showed that BI-135585 (20 hours of action) exhibited dose-dependent inhibition of the enzyme activity in perirenal adipose tissue with an IC50 of approximately 10 nM, while in abdominal subcutaneous adipose tissue the IC50 was approximately 100 nM.[1]
In vivo
BI-135585 (compound 11j; 1-3 mg/kg; orally) inhibited the enzyme activity in perirenal adipose tissue of cynomolgus monkeys by 67% and 90%, respectively. [2]
AliasBI135585, BI 135585
Chemical Properties
Molecular Weight460.57
FormulaC28H32N2O4
Cas No.1114561-85-1
SmilesC(C(C)(C)O)[C@]1(OC(=O)N([C@@H](C)C2=CC=C(C=C2)C3=CC(=O)N(C)C=C3)CC1)C4=CC=CC=C4
Relative Density.no data available
Storage & Solubility Information
Storagekeep away from moisture,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy BI-135585 | purchase BI-135585 | BI-135585 cost | order BI-135585 | BI-135585 chemical structure | BI-135585 in vivo | BI-135585 in vitro | BI-135585 formula | BI-135585 molecular weight